Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye?
Consider mast-cell activation in ASD kids with unexplained allergic symptoms; stabilizers might help this subset.
01Research in Context
What this study did
Asimenia et al. (2011) wrote a think-piece, not an experiment. They asked: could some kids with autism look "allergic" because mast cells in their skin, gut, or brain are over-active?
The team reviewed scattered case reports. They built a theory that this mast-cell subgroup might respond to allergy medicines already on the shelf.
What they found
No new data were collected. The paper ends with a call to test mast-cell stabilizers in children who show hives, flushing, diarrhea, or sudden behavior spikes that mimic allergy.
How this fits with other research
Zhou et al. (2018) gave the idea its first numbers. They measured stool IgA and found higher levels in children with ASD, showing real gut immune activity where the 2011 paper only guessed.
Zou et al. (2020) added gut bacteria data. They saw an ASD-specific microbiome pattern that could trigger the same mast cells Asimenia talked about, linking gut bugs to immune cells.
Almehmadi et al. (2020) moved the story upward. They found higher miR-155p5, an inflammation signal, in the amygdala of children with ASD, giving a brain marker that might come from mast-cell chemicals traveling through blood.
Why it matters
If you work with a child who breaks out in rashes, sudden diarrhea, or unexplained agitation, think beyond behavior plans. Track flare timing, food, and seasonal changes. Ask the pediatrician about trialing a mast-cell stabilizer or low-histamine diet while you keep data on stereotypy, sleep, or SIB. The idea is still experimental, but side effects of these drugs are well known, so a short test can be low risk and high information.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Start an ABC log that pairs each behavior surge with meals, weather, and skin notes for one week.
02At a glance
03Original abstract
Many children with Autism Spectrum Disorders (ASD) have either family and/or personal history of "allergic symptomatology", often in the absence of positive skin or RAST tests. These symptoms may suggest mast cell activation by non-allergic triggers. Moreover, children with mastocytosis or mast cell activation syndrome (MCAS), a spectrum of rare diseases characterized by increased number of activated mast cells in many organs, appear to have ASD at a rate tenfold higher (1/10 children) than that of the general population (1/100 children). Mast cell activation by allergic, infectious, environmental and stress-related triggers, especially perinatally, would release pro-inflammatory and neurotoxic molecules. We speculate these could disrupt the gut-blood-brain barriers, thus contributing to brain inflammation and ASD pathogenesis. Increased mast cell responsiveness may define at least a subgroup of ASD subjects, who could benefit from inhibition of mast cell activation.
Journal of autism and developmental disorders, 2011 · doi:10.1007/s10803-010-1171-z